| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.IMMUNI.2004.06.020 |
| P8608 | Fatcat ID | release_mjocsjv5mrhltmoksecmvgqdgu |
| P698 | PubMed publication ID | 15357947 |
| P5875 | ResearchGate publication ID | 8356072 |
| P50 | author | Govind Bhagat | Q38546986 |
| David H. Raulet | Q51794345 | ||
| Bertrand Meresse | Q58511856 | ||
| P2093 | author name string | Lewis L Lanier | |
| Thomas Spies | |||
| Veronika Groh | |||
| Peter H Green | |||
| Maria Tretiakova | |||
| Bana Jabri | |||
| Cezary Ciszewski | |||
| Zhangguo Chen | |||
| Ellen C Ebert | |||
| Thomas N Krausz | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 357-366 | |
| P577 | publication date | 2004-09-01 | |
| P1433 | published in | Immunity | Q6005457 |
| P1476 | title | Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. | |
| P478 | volume | 21 |
| Q36277983 | "Coelionomics": towards understanding the molecular pathology of coeliac disease |
| Q36407095 | 4-1BB regulates NKG2D costimulation in human cord blood CD8+ T cells |
| Q57257678 | A Protective Role for NKG2D-H60a Interaction via Homotypic T Cell Contact in Nonobese Diabetic Autoimmune Diabetes Pathogenesis |
| Q44398318 | A combined biochemical, biophysical and immunological approach towards the identification of celiac disease-specific wheat antigens |
| Q34483119 | A gluten-free diet lowers NKG2D and ligand expression in BALB/c and non-obese diabetic (NOD) mice |
| Q88321961 | A nanoscale reorganization of the IL-15 receptor is triggered by NKG2D in a ligand-dependent manner |
| Q37403775 | A selective role of NKG2D in inflammatory and autoimmune diseases |
| Q33312515 | A tertiary twist to the transglutaminase tale |
| Q33778754 | A universal approach to eliminate antigenic properties of alpha-gliadin peptides in celiac disease |
| Q83836858 | Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization |
| Q37036004 | Aberrant extrathymic T cell receptor gene rearrangement in the small intestinal mucosa: a risk factor for coeliac disease? |
| Q36652183 | Activation and self-tolerance of natural killer cells |
| Q38180339 | Advances in NKG2D ligand recognition and responses by NK cells |
| Q33709427 | Allospecific rejection of MHC class I-deficient bone marrow by CD8 T cells |
| Q34433867 | Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition. |
| Q53341128 | Altered expression of the lymphocyte activation antigen CD30 in active celiac disease. |
| Q41660377 | Anti-NKG2D mAb: A New Treatment for Crohn's Disease? |
| Q37218092 | Anti-major histocompatibility complex class I-related chain A antibodies in organ transplantation |
| Q24644114 | Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes |
| Q38289416 | Are stem cells a potential therapeutic tool in coeliac disease? |
| Q35102191 | Autoantibodies against MHC class I polypeptide-related sequence A are associated with increased risk of concomitant autoimmune diseases in celiac patients. |
| Q37051224 | Autoantibodies in celiac disease |
| Q64914645 | Beneficial Effects of Human Anti-Interleukin-15 Antibody in Gluten-Sensitive Rhesus Macaques with Celiac Disease. |
| Q37559284 | Beyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy Cells |
| Q42059394 | Bidirectional intragraft alloreactivity drives the repopulation of human intestinal allografts and correlates with clinical outcome. |
| Q54369077 | Blockade of NKG2D ameliorates disease in mice with collagen-induced arthritis: a potential pathogenic role in chronic inflammatory arthritis. |
| Q34994384 | Broad MICA/B expression in the small bowel mucosa: a link between cellular stress and celiac disease |
| Q58609021 | Bystander T Cells: A Balancing Act of Friends and Foes |
| Q28506762 | Bystander-activated memory CD8 T cells control early pathogen load in an innate-like, NKG2D-dependent manner |
| Q48127699 | CD3+ CD8+ NKG2D+ T Lymphocytes Induce Apoptosis and Necroptosis in HLA-Negative Cells via FasL-Fas Interaction. |
| Q39042122 | CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes |
| Q33390838 | CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin |
| Q91062575 | CXCR3 enables recruitment and site-specific bystander activation of memory CD8+ T cells |
| Q28114853 | Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits proximal TCR signaling by targeting ZAP-70 |
| Q36015747 | Celiac Disease-Related Inflammation Is Marked by Reduction of Nkp44/Nkp46-Double Positive Natural Killer Cells |
| Q59813523 | Celiac Disease: A Review of Current Concepts in Pathogenesis, Prevention, and Novel Therapies |
| Q50876572 | Celiac disease resolution after allogeneic bone marrow transplantation is associated with absence of gliadin-specific memory response by donor-derived intestinal T-cells. |
| Q34903220 | Celiac disease: from oral tolerance to intestinal inflammation, autoimmunity and lymphomagenesis. |
| Q34128112 | Celiac disease: how complicated can it get? |
| Q36698131 | Celiac disease: pathogenesis of a model immunogenetic disease |
| Q24658242 | Celiac disease: pathophysiology, clinical manifestations, and associated autoimmune conditions |
| Q26865115 | Celiac disease: quantity matters |
| Q34831592 | Celiac disease: risk assessment, diagnosis, and monitoring |
| Q38184586 | Celiac disease: the search for adjunctive or alternative therapies |
| Q38873776 | Celiac disease: understanding the gluten-free diet |
| Q33410094 | Cellular expression, trafficking, and function of two isoforms of human ULBP5/RAET1G. |
| Q24616204 | Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens |
| Q98177686 | Coeliac Disease Pathogenesis: The Uncertainties of a Well-Known Immune Mediated Disorder |
| Q95389546 | Coeliac disease |
| Q28235200 | Coeliac disease and gluten sensitivity |
| Q28263872 | Coeliac disease and gluten-related disorders in childhood |
| Q37767725 | Coeliac disease--a diagnostic and therapeutic challenge |
| Q28073430 | Coeliac disease: a unique model for investigating broken tolerance in autoimmunity |
| Q34571582 | Coeliac disease: an update for pathologists |
| Q28069527 | Convergence of Innate and Adaptive Immunity during Human Aging |
| Q38815326 | Cooperative therapeutic anti-tumor effect of IL-15 agonist ALT-803 and co-targeting soluble NKG2D ligand sMIC |
| Q36429508 | Cooperativity of adaptive and innate immunity: implications for cancer therapy |
| Q34402566 | Costimulation of dendritic epidermal gammadelta T cells by a new NKG2D ligand expressed specifically in the skin |
| Q83948516 | Cross-dressing T cells go wild |
| Q27680609 | Crystal Structure of Vδ1 T Cell Receptor in Complex with CD1d-Sulfatide Shows MHC-like Recognition of a Self-Lipid by Human γδ T Cells |
| Q36080707 | Cysteinyl leukotrienes mediate lymphokine killer activity induced by NKG2D and IL-15 in cytotoxic T cells during celiac disease |
| Q37148152 | Cytokines in cancer immunotherapy |
| Q41330986 | Cytosolic PLA2 is required for CTL-mediated immunopathology of celiac disease via NKG2D and IL-15. |
| Q39227235 | DNA demethylation and histone H3K9 acetylation determine the active transcription of the NKG2D gene in human CD8+ T and NK cells |
| Q31120923 | Deamidated gliadin peptides as targets for celiac disease-specific antibodies. |
| Q35953847 | Deficiency of invariant natural killer T cells in coeliac disease |
| Q41882445 | Diagnostic and therapeutic strategies for eosinophilic esophagitis |
| Q26823584 | Dietary gluten and the development of type 1 diabetes |
| Q37088595 | Dietary gluten triggers concomitant activation of CD4+ and CD8+ αβ T cells and γδ T cells in celiac disease |
| Q84479921 | Dietary strategies of immunomodulation in infants at risk for celiac disease |
| Q37016414 | Distinct activation thresholds of human conventional and innate-like memory T cells |
| Q35998352 | Distinct and Synergistic Contributions of Epithelial Stress and Adaptive Immunity to Functions of Intraepithelial Killer Cells and Active Celiac Disease |
| Q57270695 | Distinct human circulating NKp30FcεRIγCD8 T cell population exhibiting high natural killer-like antitumor potential |
| Q88538287 | Diverse developmental pathways of intestinal intraepithelial lymphocytes |
| Q24338539 | Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142 |
| Q83164356 | Dynamics of non-conventional intraepithelial lymphocytes-NK, NKT, and γδ T-in celiac disease: relationship with age, diet, and histopathology |
| Q42403528 | Effector and suppressor T cells in celiac disease |
| Q33772145 | Efficient cross-priming of tumor antigen-specific T cells by dendritic cells sensitized with diverse anti-MICA opsonized tumor cells |
| Q40460772 | Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells. |
| Q35105666 | Engagement of NKG2D on bystander memory CD8 T cells promotes increased immunopathology following Leishmania major infection |
| Q89047050 | Epithelial IL-15 Is a Critical Regulator of γδ Intraepithelial Lymphocyte Motility within the Intestinal Mucosa |
| Q37774241 | Epithelial decision makers: in search of the 'epimmunome'. |
| Q35760432 | Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. |
| Q36484117 | Evidence for differential roles for NKG2D receptor signaling in innate host defense against coronavirus-induced neurological and liver disease |
| Q40207796 | Expression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus. |
| Q53279828 | Expression and function of the natural cytotoxicity receptor NKp46 on circulating malignant CD4+ T lymphocytes of Sézary syndrome patients. |
| Q54627236 | Expression of the NKG2D ligand UL16 binding protein-1 (ULBP-1) on dendritic cells. |
| Q34652549 | Expression, signaling proficiency, and stimulatory function of the NKG2D lymphocyte receptor in human cancer cells |
| Q53620715 | Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity. |
| Q41944148 | Functional Dichotomy between NKG2D and CD28-Mediated Co-Stimulation in Human CD8+ T Cells |
| Q40150197 | Functional restoration of CD56(bright) NK cells facilitates immune control via IL-15 and NKG2D in patients under antiviral treatment for chronic hepatitis B. |
| Q50199706 | Functions of NKG2D in CD8+ T cells: an opportunity for immunotherapy. |
| Q36304110 | Future therapeutic options for celiac disease |
| Q36024156 | Gamma c cytokines condition the progressive differentiation of CD4+ T cells |
| Q35869122 | Gliadin activates HLA class I-restricted CD8+ T cells in celiac disease intestinal mucosa and induces the enterocyte apoptosis |
| Q41951345 | Gliadin fragments promote migration of dendritic cells |
| Q57600343 | Gliadin intake alters the small intestinal mucosa in indomethacin-treated HLA-DQ8 transgenic mice |
| Q27321328 | Gliadin peptide P31-43 localises to endocytic vesicles and interferes with their maturation |
| Q79680822 | Gliadin peptides activate blood monocytes from patients with celiac disease |
| Q34447313 | Gliadin peptides as triggers of the proliferative and stress/innate immune response of the celiac small intestinal mucosa |
| Q33833760 | Gliadin-mediated proliferation and innate immune activation in celiac disease are due to alterations in vesicular trafficking |
| Q64102468 | Gluten Free Wheat: Are We There? |
| Q36224141 | Gluten: a two-edged sword. Immunopathogenesis of celiac disease |
| Q35498128 | Gut microbes and adverse food reactions: Focus on gluten related disorders |
| Q48113441 | Gut microbiome: a new player in gastrointestinal disease |
| Q43875412 | Gut microbiota regulates NKG2D ligand expression on intestinal epithelial cells. |
| Q28280749 | HLA-DQB1*0201 homozygosis predisposes to severe intestinal damage in celiac disease |
| Q33750016 | Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines. |
| Q47247103 | Heterogeneity of asthma and the risk of celiac disease in children |
| Q51060704 | High Smad7 sustains inflammatory cytokine response in refractory coeliac disease. |
| Q46562246 | High prevalence of celiac disease among patients affected by Crohn's disease |
| Q54514144 | Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients. |
| Q47161100 | How Mucosal Epithelia Deal with Stress: Role of NKG2D/NKG2D Ligands during Inflammation. |
| Q36732703 | Human CD8+ intraepithelial lymphocytes: a unique model to study the regulation of effector cytotoxic T lymphocytes in tissue |
| Q33522918 | Human IgG1 antibodies antagonizing activating receptor NKG2D on natural killer cells |
| Q21131219 | Human NKG2D-ligands: cell biology strategies to ensure immune recognition |
| Q61248561 | Human intraepithelial lymphocytes |
| Q55006062 | Human γδ T-Cell Control of Mucosal Immunity and Inflammation. |
| Q90440122 | IL-10 signaling prevents gluten-dependent intraepithelial CD4+ cytotoxic T lymphocyte infiltration and epithelial damage in the small intestine |
| Q40577301 | IL-12 Signals through the TCR To Support CD8 Innate Immune Responses |
| Q37364736 | IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction |
| Q36855263 | IL-15 in tumor microenvironment causes rejection of large established tumors by T cells in a noncognate T cell receptor-dependent manner |
| Q51630681 | IL-15 is critical for the maintenance and innate functions of self-specific CD8(+) T cells. |
| Q46309160 | IL-15 positively regulates IL-21 production in celiac disease mucosa. |
| Q24604346 | IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis |
| Q89686918 | IL-15, gluten and HLA-DQ8 drive tissue destruction in coeliac disease |
| Q35995167 | IL-15, in synergy with RAE-1ɛ, stimulates TCR-independent proliferation and activation of CD8(+) T cells |
| Q33788829 | IL-15: a central regulator of celiac disease immunopathology |
| Q38138107 | IL-17 producing T cells in celiac disease: angels or devils? |
| Q45987254 | IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines. |
| Q35691185 | IRF-1 promotes liver transplant ischemia/reperfusion injury via hepatocyte IL-15/IL-15Rα production |
| Q35033191 | ITK and IL-15 support two distinct subsets of CD8+ T cells |
| Q24538575 | Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue |
| Q33823074 | Identification of gliadin-binding peptides by phage display |
| Q42628303 | Immune activation resulting from NKG2D/ligand interaction promotes atherosclerosis |
| Q27026098 | Immune development and intestinal microbiota in celiac disease |
| Q37077413 | Immunobiology and conflicting roles of the human NKG2D lymphocyte receptor and its ligands in cancer |
| Q38380946 | Immunochemical Detection Methods for Gluten in Food Products: Where Do We Go from Here? |
| Q36027518 | Immunogenetic Pathogenesis of Celiac Disease and Non-celiac Gluten Sensitivity. |
| Q34467128 | Immunogenetic biomarkers in inflammatory bowel diseases: role of the IBD3 region |
| Q38001050 | Immunological pathways in virus-induced COPD exacerbations: a role for IL-15. |
| Q38783192 | Immunopathogenesis and therapeutic approaches in pediatric celiac disease |
| Q81980710 | Immunopathogenesis of celiac disease |
| Q38885843 | Immunostimulation by induced expression of NKG2D and its MIC ligands in HTLV-1-associated neurologic disease |
| Q33287471 | In vivo expression pattern of MICA and MICB and its relevance to auto-immunity and cancer |
| Q45401996 | Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells |
| Q42857041 | Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal |
| Q81150553 | Infiltration of forkhead box P3-expressing cells in small intestinal mucosa in coeliac disease but not in type 1 diabetes |
| Q49693642 | Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis |
| Q42277216 | Influenza infection results in local expansion of memory CD8(+) T cells with antigen non-specific phenotype and function. |
| Q45325513 | Innate immunity protein Tag7 (PGRP-S) activates lymphocytes capable of Fasl-Fas-dependent contact killing of virus-infected cells. |
| Q35733419 | Innate immunity: actuating the gears of celiac disease pathogenesis |
| Q45772566 | Innate-like T cells straddle innate and adaptive immunity by altering antigen-receptor responsiveness. |
| Q37417482 | Integration of cytokine and heterologous receptor signaling pathways |
| Q41115758 | Interleukin 15 controls the generation of the restricted T cell receptor repertoire of gamma delta intestinal intraepithelial lymphocytes |
| Q35006277 | Interleukin 15 primes natural killer cells to kill via NKG2D and cPLA2 and this pathway is active in psoriatic arthritis |
| Q36419076 | Interleukin 15: its role in intestinal inflammation. |
| Q35850624 | Interleukin-15 Constrains Mucosal T Helper 17 Cell Generation: Influence of Mononuclear Phagocytes |
| Q37452839 | Interleukin-15 enhances proteasomal degradation of bid in normal lymphocytes: implications for large granular lymphocyte leukemias |
| Q33975785 | Interleukin-15 expression is increased in human eosinophilic esophagitis and mediates pathogenesis in mice. |
| Q83163662 | Interleukin-15 mediates protection against experimental tuberculosis: a role for NKG2D-dependent effector mechanisms of CD8+ T cells |
| Q51318148 | Interleukin-15 plays an essential role in the pathogenesis of autoimmune diabetes in the NOD mouse. |
| Q58619639 | Interleukins 12 and 15 induce cytotoxicity and early NK-cell differentiation in type 3 innate lymphoid cells |
| Q42700216 | Intestinal Barrier Interactions with Specialized CD8 T Cells |
| Q46151992 | Intestinal Epithelial and Intraepithelial T Cell Crosstalk Mediates a Dynamic Response to Infection |
| Q37522003 | Intestinal macrophages: differentiation and involvement in intestinal immunopathologies. |
| Q35803031 | Intestinal microbiota modulates gluten-induced immunopathology in humanized mice |
| Q38015720 | Intraepithelial lymphocytes in celiac disease immunopathology |
| Q36732679 | Intraepithelial lymphocytes: their shared and divergent immunological behaviors in the small and large intestine |
| Q37638684 | Investigational therapies for celiac disease |
| Q42573421 | Involvement of interleukin-15 and interleukin-21, two gamma-chain-related cytokines, in celiac disease |
| Q24674588 | Is gliadin really safe for non-coeliac individuals? Production of interleukin 15 in biopsy culture from non-coeliac individuals challenged with gliadin peptides |
| Q36498465 | JNK MAP kinase activation is required for MTOC and granule polarization in NKG2D-mediated NK cell cytotoxicity |
| Q38263650 | Lessons from rodent models in celiac disease |
| Q34005464 | Licensing virus-specific T cells to secrete the neutrophil attracting chemokine CXCL-8 during hepatitis B virus infection |
| Q36930253 | Line of attack: NK cell specificity and integration of signals |
| Q50860383 | Lnk prevents inflammatory CD8⁺ T-cell proliferation and contributes to intestinal homeostasis. |
| Q33728531 | Local Inflammatory Cues Regulate Differentiation and Persistence of CD8+ Tissue-Resident Memory T Cells |
| Q36023429 | Long-term follow-up of 61 coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet |
| Q88221891 | MICA/B expression in macrophage foam cells infiltrating atherosclerotic plaques |
| Q38008345 | Manipulation of NKG2D ligands by cytomegaloviruses: impact on innate and adaptive immune response. |
| Q35748643 | Many NK cell receptors activate ERK2 and JNK1 to trigger microtubule organizing center and granule polarization and cytotoxicity |
| Q94948692 | Mechanisms of activation of innate-like intraepithelial T lymphocytes |
| Q36585030 | Mechanisms of disease: immunopathogenesis of celiac disease |
| Q33886458 | Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models |
| Q34798574 | Modeling of celiac disease immune response and the therapeutic effect of potential drugs |
| Q36252174 | Molecular mechanisms of the adaptive, innate and regulatory immune responses in the intestinal mucosa of celiac disease patients |
| Q55234629 | More than Decoration: Roles for Natural Killer Group 2 Member D Ligand Expression by Immune Cells. |
| Q36148741 | Mucosal T lymphocytes--peacekeepers and warriors |
| Q38450836 | Mucosal histopathology in celiac disease: a rebuttal of Oberhuber's sub-division of Marsh III. |
| Q36543814 | NK cell receptors as tools in cancer immunotherapy. |
| Q37088602 | NK cells and their receptors |
| Q46935653 | NK cells do not mediate renal injury in murine adriamycin nephropathy |
| Q35591444 | NK cells: immune cross-talk and therapeutic implications |
| Q33844629 | NK1.1- CD4+ NKG2D+ T cells suppress DSS-induced colitis in mice through production of TGF-β |
| Q42628431 | NKG2D Initiates Caspase-Mediated CD3ζ Degradation and Lymphocyte Receptor Impairments Associated with Human Cancer and Autoimmune Disease |
| Q35687826 | NKG2D Receptor and Its Ligands in Host Defense |
| Q54234609 | NKG2D and Its Ligands: "One for All, All for One". |
| Q35692428 | NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT |
| Q36354709 | NKG2D in NK and T cell-mediated immunity |
| Q27014888 | NKG2D ligands as therapeutic targets |
| Q37287179 | NKG2D ligands in tumor immunity |
| Q36469236 | NKG2D performs two functions in invariant NKT cells: direct TCR-independent activation of NK-like cytolysis and co-stimulation of activation by CD1d |
| Q35778154 | NKG2D recognition mediates Toll-like receptor 3 signaling-induced breakdown of epithelial homeostasis in the small intestines of mice |
| Q38194944 | NKG2D signaling in cancer immunosurveillance |
| Q63363683 | NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway |
| Q36215821 | NKG2D signaling on CD8⁺ T cells represses T-bet and rescues CD4-unhelped CD8⁺ T cell memory recall but not effector responses |
| Q52576677 | NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis. |
| Q34508406 | NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells |
| Q38808106 | NKp46+ CD3+ cells: a novel nonconventional T cell subset in cattle exhibiting both NK cell and T cell features |
| Q36701917 | Natural cytotoxicity receptors: broader expression patterns and functions in innate and adaptive immune cells. |
| Q37805560 | Natural killer cells in human autoimmune diseases |
| Q58092158 | Natural killer cells in lung transplantation |
| Q42846586 | New aspects in celiac disease |
| Q37905046 | New clues in celiac disease epidemiology, pathogenesis, clinical manifestations, and treatment |
| Q83235704 | New directions in multiple sclerosis therapy: matching therapy with pathogenesis |
| Q37273292 | Normally occurring NKG2D+CD4+ T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupus |
| Q35657347 | Novel players in coeliac disease pathogenesis: role of the gut microbiota |
| Q34170574 | Novel therapies for coeliac disease |
| Q43461538 | Oligoclonal expansions of mucosal T cells in Crohn's disease predominate in NKG2D-expressing CD4 T cells |
| Q42061479 | Oral proteases: a new approach to managing coeliac disease |
| Q37333365 | Orally based diagnosis of celiac disease: current perspectives |
| Q33573305 | PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage |
| Q33329537 | Parallels between pathogens and gluten peptides in celiac sprue |
| Q89251125 | Pathogenesis of Enteropathy-Associated T Cell Lymphoma |
| Q34307239 | Pathophysiology of celiac disease |
| Q36542810 | Phase 1 trial of IL-15 trans presentation blockade using humanized Mikβ1 mAb in patients with T-cell large granular lymphocytic leukemia |
| Q40070389 | Phosphatidylinositol 3-kinase activation is required to form the NKG2D immunological synapse |
| Q36539486 | Possible drug targets for celiac disease |
| Q36045773 | Potential role of natural killer cell receptor-expressing cells in immunotherapy for leukemia |
| Q37060405 | Premature cell senescence and T cell receptor-independent activation of CD8+ T cells in juvenile idiopathic arthritis |
| Q92307503 | Prevalance of Celiac Disease in Patients with Inflammatory Bowel Disease in Turkish Population |
| Q84153190 | Prevalence of the NKG2D Thr72Ala polymorphism in patients with systemic lupus erythematosus |
| Q34623902 | Prevention measures and exploratory pharmacological treatments of celiac disease. |
| Q27027791 | Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology |
| Q58327078 | Prolamins of maize and wheat differentially affect intestinal cells both in biopsies of celiac patients and CACO-2 cell line |
| Q36900826 | Promiscuity and the single receptor: NKG2D. |
| Q36107413 | Propionibacterium acnes overabundance and natural killer group 2 member D system activation in corpus-dominant lymphocytic gastritis |
| Q61800044 | Protective Effects of Aryl Hydrocarbon Receptor Signaling in Celiac Disease Mucosa and in Poly I:C-Induced Small Intestinal Atrophy Mouse Model |
| Q37772795 | Proteomic analyses lead to a better understanding of celiac disease: focus on epitope recognition and autoantibodies. |
| Q36412214 | Quantification of anti-sperm antibody and soluble MICA/MICB levels in the serum of infertile people of the Li ethnic group in China |
| Q40980436 | RAE1ε ligand expressed on pancreatic islets recruits NKG2D receptor-expressing cytotoxic T cells independent of T cell receptor recognition |
| Q28300038 | RAET1E2, a soluble isoform of the UL16-binding protein RAET1E produced by tumor cells, inhibits NKG2D-mediated NK cytotoxicity |
| Q22306523 | Recent advances in coeliac disease |
| Q38027424 | Refractory celiac disease: from bench to bedside |
| Q26825247 | Regulating the immune system via IL-15 transpresentation |
| Q40098295 | Regulation of NKG2D-Dependent NK Cell Functions: The Yin and the Yang of Receptor Endocytosis |
| Q24635093 | Regulation of immune cell function and differentiation by the NKG2D receptor |
| Q34321457 | Regulation of ligands for the NKG2D activating receptor |
| Q36872056 | Regulation of ligands for the activating receptor NKG2D. |
| Q40254093 | Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease. |
| Q36238119 | Reprogramming of CTLs into natural killer-like cells in celiac disease |
| Q46734905 | Restricted expression of C-type lectin-like natural killer receptors by CD8 T cells in the murine small intestine |
| Q36605917 | Reversal of epigenetic silencing of MHC class I chain-related protein A and B improves immune recognition of Merkel cell carcinoma |
| Q34253519 | Review article: coeliac disease, new approaches to therapy. |
| Q28297550 | Review article: safe amounts of gluten for patients with wheat allergy or coeliac disease |
| Q35106620 | Role of CXCR3/CXCL10 axis in immune cell recruitment into the small intestine in celiac disease |
| Q28085758 | Role of the intestinal cytokine microenvironment in shaping the intraepithelial lymphocyte repertoire |
| Q34009143 | Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease |
| Q39252045 | Selective inhibition of the gliadin-specific, cell-mediated immune response by transamidation with microbial transglutaminase |
| Q49834319 | Sentinels at the frontline: the role of intraepithelial lymphocytes in inflammatory bowel disease |
| Q34474911 | Serum parameters in the spectrum of coeliac disease: beyond standard antibody testing--a cohort study |
| Q43209848 | Serum soluble major histocompatibility complex class I-related chain A/B expression in patients with alcoholic liver disease in Hainan Li community |
| Q36403003 | Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells |
| Q36227215 | Small intestinal CD8+TCRgammadelta+NKG2A+ intraepithelial lymphocytes have attributes of regulatory cells in patients with celiac disease. |
| Q49865270 | Soluble MICB in Plasma and Urine Explains Population Expansions of NKG2D+CD4 T Cells Inpatients with Juvenile-Onset Systemic Lupus Erythematosus |
| Q41274673 | Specificity may be overrated in cancer immunotherapy: Getting to know the nonspecific side of memory T Cells |
| Q40382191 | Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance |
| Q38893279 | T Cells Going Innate |
| Q39217707 | T Cells in Celiac Disease. |
| Q80113417 | TCR-independent cytokine stimulation induces non-MHC-restricted T cell activity and is negatively regulated by HLA class I |
| Q55285823 | Tag7 (PGLYRP1) Can Induce an Emergence of the CD3+CD4+CD25+CD127+ Cells with Antitumor Activity. |
| Q27312407 | Targeting the binding interface on a shared receptor subunit of a cytokine family enables the inhibition of multiple member cytokines with selectable target spectrum |
| Q42108663 | Tetramer-visualized gluten-specific CD4+ T cells in blood as a potential diagnostic marker for coeliac disease without oral gluten challenge. |
| Q34424423 | The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells |
| Q35668237 | The Interaction among Microbiota, Immunity, and Genetic and Dietary Factors Is the Condicio Sine Qua Non Celiac Disease Can Develop. |
| Q37056344 | The NKG2D receptor: immunobiology and clinical implications. |
| Q36685376 | The NKG2D-IL-15 signaling pathway contributes to T-cell mediated pathology in inflammatory myopathies |
| Q55001650 | The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease. |
| Q58785685 | The Paradoxical Role of NKG2D in Cancer Immunity |
| Q55431606 | The Role of Natural Killer Group 2, Member D in Chronic Inflammation and Autoimmunity. |
| Q55222890 | The Role of T-Cell Subsets in Chronic Inflammation in Celiac Disease and Inflammatory Bowel Disease Patients: More Common Mechanisms or More Differences? |
| Q24676700 | The SPINK gene family and celiac disease susceptibility |
| Q33836365 | The activating NKG2D receptor assembles in the membrane with two signaling dimers into a hexameric structure. |
| Q91890884 | The activation of bystander CD8+ T cells and their roles in viral infection |
| Q36547207 | The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design |
| Q38875858 | The composition and differentiation potential of the duodenal intraepithelial innate lymphocyte compartment is altered in coeliac disease |
| Q36271532 | The composition of T cell subtypes in duodenal biopsies are altered in coeliac disease patients |
| Q26744126 | The cross-talk between enterocytes and intraepithelial lymphocytes |
| Q57143881 | The elusive case of human intraepithelial T cells in gut homeostasis and inflammation |
| Q39904639 | The expression and function of NKG2D molecule on intrahepatic CD8+ T cells in chronic viral hepatitis |
| Q38016781 | The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet |
| Q37622429 | The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma |
| Q35119562 | The light and dark sides of intestinal intraepithelial lymphocytes |
| Q34444067 | The present and the future in the diagnosis and management of celiac disease |
| Q39038947 | The progression of coeliac disease: its neurological and psychiatric implications |
| Q84462998 | The protective effect of oral colitis-derived proteins in a murine model of inflammatory bowel disease is associated with an increase in gammadelta T cells in large intestinal mucosa |
| Q92980062 | The role of CXCR3 and its ligands CXCL10 and CXCL11 in the pathogenesis of celiac disease |
| Q36736188 | The target tissue in autoimmunity--an influential niche |
| Q38163884 | The unique surface molecules on intestinal intraepithelial lymphocytes: from tethering to recognizing |
| Q26825413 | Therapeutic approaches for celiac disease |
| Q34694955 | Therapy-induced antibodies to MHC class I chain-related protein A antagonize immune suppression and stimulate antitumor cytotoxicity |
| Q39255569 | Tissue adaptation: Implications for gut immunity and tolerance. |
| Q37638199 | Tissue-mediated control of immunopathology in coeliac disease |
| Q36675105 | Tofacitinib, a janus kinase inhibitor demonstrates efficacy in an IL-15 transgenic mouse model that recapitulates pathologic manifestations of celiac disease |
| Q91994807 | Transcriptional profiling of human intestinal plasma cells reveals effector functions beyond antibody production |
| Q61441007 | Transcriptional regulation of MICA and MICB: A novel polymorphism in MICB promoter alters transcriptional regulation by Sp1 |
| Q84973051 | Transgenic mice that overexpress human IL-15 in enterocytes recapitulate both B and T cell-mediated pathologic manifestations of celiac disease |
| Q21092747 | Transglutaminase 2 undergoes a large conformational change upon activation |
| Q52358106 | Translational Chemistry Meets Gluten-Related Disorders. |
| Q37283086 | Triggers and drivers of autoimmunity: lessons from coeliac disease |
| Q37315679 | Tumor cell recognition by the NK cell activating receptor NKG2D. |
| Q37039243 | Umbilical cord blood T cells express multiple natural cytotoxicity receptors after IL-15 stimulation, but only NKp30 is functional |
| Q41247751 | Uncontrolled IL-17 Production by Intraepithelial Lymphocytes in a Case of non-IPEX Autoimmune Enteropathy |
| Q36793674 | Understanding the molecular basis of celiac disease: what genetic studies reveal |
| Q29619175 | Up on the tightrope: natural killer cell activation and inhibition |
| Q55019451 | Working in "NK Mode": Natural Killer Group 2 Member D and Natural Cytotoxicity Receptors in Stress-Surveillance by γδ T Cells. |
| Q52903951 | [New therapeutic approaches to special diseases of the small intestine]. |
| Q58586469 | iNKT Cells Suppress Pathogenic NK1.1CD8 T Cells in DSS-Induced Colitis |
| Q96952227 | mTOR sustains inflammatory response in celiac disease |
Search more.